1. Home
  2. IMNM vs FRSX Comparison

IMNM vs FRSX Comparison

Compare IMNM & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • FRSX
  • Stock Information
  • Founded
  • IMNM 2006
  • FRSX N/A
  • Country
  • IMNM United States
  • FRSX Israel
  • Employees
  • IMNM N/A
  • FRSX N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • FRSX Computer Software: Prepackaged Software
  • Sector
  • IMNM Health Care
  • FRSX Technology
  • Exchange
  • IMNM Nasdaq
  • FRSX Nasdaq
  • Market Cap
  • IMNM 747.7M
  • FRSX 31.1M
  • IPO Year
  • IMNM 2020
  • FRSX 2017
  • Fundamental
  • Price
  • IMNM $10.25
  • FRSX $1.65
  • Analyst Decision
  • IMNM Strong Buy
  • FRSX
  • Analyst Count
  • IMNM 5
  • FRSX 0
  • Target Price
  • IMNM $28.60
  • FRSX N/A
  • AVG Volume (30 Days)
  • IMNM 856.1K
  • FRSX 1.8M
  • Earning Date
  • IMNM 11-13-2024
  • FRSX 11-29-2024
  • Dividend Yield
  • IMNM N/A
  • FRSX N/A
  • EPS Growth
  • IMNM N/A
  • FRSX N/A
  • EPS
  • IMNM N/A
  • FRSX N/A
  • Revenue
  • IMNM $10,129,000.00
  • FRSX $473,000.00
  • Revenue This Year
  • IMNM N/A
  • FRSX N/A
  • Revenue Next Year
  • IMNM N/A
  • FRSX N/A
  • P/E Ratio
  • IMNM N/A
  • FRSX N/A
  • Revenue Growth
  • IMNM N/A
  • FRSX 3.28
  • 52 Week Low
  • IMNM $8.97
  • FRSX $0.57
  • 52 Week High
  • IMNM $30.96
  • FRSX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 34.53
  • FRSX 64.88
  • Support Level
  • IMNM $10.67
  • FRSX $1.63
  • Resistance Level
  • IMNM $11.28
  • FRSX $2.63
  • Average True Range (ATR)
  • IMNM 0.76
  • FRSX 0.32
  • MACD
  • IMNM -0.27
  • FRSX 0.12
  • Stochastic Oscillator
  • IMNM 0.63
  • FRSX 52.60

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its advanced systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: